CCNE
CNB Financial Corporation
CCNE offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
MS
Morgan Stanley
MS has a slight edge over CCNE overall, supported by stronger valuation and stronger modeled upside.
CCNE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
CCNE's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like CCNE.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
CCNE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $22.90 | -36% |
| Fair | 9.4x | $31.75 | -11% |
| Forward | 9.8x | $35.64 | — |
| Current | 11x | $35.64 | — |
| Expensive | 12x | $41.88 | +17% |
Historical ranges are pointers, not guarantees.
CCNE has the edge over MS in the historical PE scenario, which offers more potential upside but is not a forecast.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
CCNE Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CCNE, with profitability improving.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for MS, with profitability improving.
CCNE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.64 | +8.2% |
| Q3 2026 | $3.36 | +68% |
| Q2 2026 | $2.67 | +12% |
| Q1 2026 | $2.37 | +1.3% |
| Q4 2025 | $1.99 | -17% |
| Q3 2025 | $2.00 | -14% |
| Q2 2025 | $2.39 | +3% |
| Q1 2025 | $2.34 | -1.3% |
| Q4 2024 | $2.39 | -6.3% |
CCNE earned $3.36 per share over the past year, up 68% from the year before.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the edge over CCNE on earnings, with more consistent year-over-year improvement.
CCNE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $87.8M | +13% |
| Q2 2026 | $87.6M | +43% |
| Q1 2026 | $83.3M | +46% |
| Q4 2025 | $86.4M | +45% |
| Q3 2025 | $77.7M | +33% |
| Q2 2025 | $61.2M | +12% |
| Q1 2025 | $56.9M | +5.1% |
| Q4 2024 | $59.4M | +4.5% |
CCNE has the edge over MS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 38% | +26 points |
| Q2 2026 | 40% | +12 points |
| Q1 2026 | 40% | +15 points |
| Q4 2025 | 48% | +17 points |
| Q3 2025 | 12% | -18 points |
| Q2 2025 | 28% | -1.1 points |
| Q1 2025 | 25% | -3.3 points |
| Q4 2024 | 31% | +1.2 points |
CCNE has the edge over MS on profitability, with a higher operating margin.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS's operating margin was 32% last quarter, down 1.2 points from the same quarter a year ago.
CCNE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.6M | -26% |
| Q2 2026 | $36M | +101% |
| Q1 2026 | $18.8M | +91% |
| Q4 2025 | $26M | +38% |
| Q3 2025 | $4.9M | -78% |
| Q2 2025 | $17.9M | +332% |
| Q1 2025 | $9.9M | -1.4% |
| Q4 2024 | $18.8M | +19% |
CCNE has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
CCNE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +41K shares |
| 1 year | +8.3% | +2.3M shares |
| 3 years | +41% | +8.6M shares |
| 5 years | +75% | +12.7M shares |
| Available history | +95% | +14.4M shares |
CCNE has 30M diluted shares, up 8.3% from a year ago.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over CCNE on shareholder dilution, with a more favorable share count trend.
CCNE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.8x | Net Cash |
| Q2 2026 | -1.9x | Net Cash |
| Q1 2026 | -3.1x | Net Cash |
| Q4 2025 | -3.0x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -4.5x | Net Cash |
| Q1 2025 | -5.8x | Net Cash |
| Q4 2024 | -4.7x | Net Cash |
CCNE has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
CCNE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 64.7 | Neutral |
| Stochastic | 66.7 | Neutral |
CCNE's weekly RSI is 65 (neutral) and its Stochastic is 67 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
CCNE PE vs Financial Services Sector
| Metric | CCNE | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 71 | 63 | 8 pts above |
CCNE has the edge over MS on valuation relative to its sector.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
CCNE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $34.7 | 2.6% above |
| 20 week MA | $34.5 | 3.3% above |
| 50 week MA | $31.3 | 14% above |
| 100 week MA | $27.6 | 29% above |
| 200 week MA | $24.3 | 47% above |
CCNE has the edge over MS on trend strength, trading above more of its moving averages.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
CCNE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $32.8 | $20.9 | -36% |
| 2021 | $20.9 | $26.7 | +28% |
| 2022 | $26.7 | $24.1 | -9.7% |
| 2023 | $24.1 | $22.6 | -6.3% |
| 2024 | $22.6 | $24.9 | +10% |
| 2025 | $24.9 | $26.8 | +7.7% |
| 2026 YTD | $26.8 | $35.6 | +33% |
CCNE has the edge over MS on returns for 2026, with the stronger performance.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has finished higher in five of the last six years. It's up 4% so far in 2026.